Invictus Ventures is a pioneering healthcare technology company revolutionizing the pharmacy landscape by dismantling opaque barriers in traditional Pharmacy Benefit Managers (PBMs). Our mission: Make prescription drugs affordable, accessible, and transparent for all, using blockchain, AI, and stablecoins to connect patients, providers, pharmacies, and payers in real time.

We address issues from reports like the 2019 Milliman white paper, which highlights blockchain's potential to disrupt PBM-payer-pharmacy relationships. PBMs emerged in the 1980s to handle complex claims but now control 70-75% of U.S. prescriptions via giants like CVS Caremark, OptumRx, and Express Scripts. This leads to hidden rebates, spread pricing, and inflated costs. Invictus counters with immutable ledgers for instant POS reimbursements, smart contracts for fair pricing, and AI for eligibility verification—reducing fraud by up to 40% and delays from 90 days to seconds.

Our Invictus Pharmacy platform integrates retail, mail-order, specialty, and compounding into a nationwide network targeting 5,000 partners. We focus on GLP-1 therapies, hormone replacement, and patient assistance programs (PAPs), partnering with telemedicine and manufacturers for growth. Features include USDC payments with yields (up to 4.8% on float), enabling zero-fee, compliant transactions.

In January 2026, with FTC scrutiny on PBM practices and GLP-1 shortages ending, we're primed for expansion. Our team emphasizes data moats—monetizing anonymized prescription insights for AI training, forecasting $5M in data revenue by Year 4.

Join our movement for equitable healthcare: Tech that sells itself, empowering patients with cost transparency and pharmacies with earnings. #HealthTech #BlockchainInHealthcare #AffordableRx

Invictus Ventures

Org chart

Teams

Offices

Invictus Ventures

Org chart

Teams

Offices

Related companies